Header cover image

U.S. Biotech Industry Analysis

UpdatedApr 21, 2026
DataAggregated Company Financials
Companies549
  • 7D1.7%
  • 3M6.2%
  • 1Y43.3%
  • YTD7.1%

The Biotech industry is up 1.7% in the last week, with Summit Therapeutics up 27%. In the last 12 months, the industry was up 43%. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the U.S. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 22 Apr 2026US$1.3tUS$166.2b-US$11,955,091,151.1917.1x-112.7x8.1x
Fri, 20 Mar 2026US$1.3tUS$169.3b-US$15,232,711,632.1115.4x-83.5x7.5x
Sun, 15 Feb 2026US$1.3tUS$168.7b-US$13,693,089,252.4222.2x-97.5x7.9x
Tue, 13 Jan 2026US$1.2tUS$163.5b-US$15,146,265,061.8720.8x-80.9x7.5x
Thu, 11 Dec 2025US$1.2tUS$163.6b-US$15,616,288,786.2519.2x-77.3x7.4x
Sat, 08 Nov 2025US$1.1tUS$163.2b-US$15,904,863,908.5716.2x-71.3x6.9x
Mon, 06 Oct 2025US$1.1tUS$163.5b-US$18,204,873,215.1716.7x-62.3x6.9x
Wed, 03 Sep 2025US$1.1tUS$163.5b-US$18,341,149,050.4115.4x-57.6x6.5x
Fri, 01 Aug 2025US$977.1bUS$155.6b-US$21,869,816,647.1615.7x-44.7x6.3x
Sun, 29 Jun 2025US$927.2bUS$156.0b-US$23,836,878,936.0917.2x-38.9x5.9x
Tue, 27 May 2025US$907.6bUS$156.0b-US$24,117,883,283.5915.6x-37.6x5.8x
Thu, 24 Apr 2025US$786.0bUS$119.2b-US$36,559,322,741.4119.7x-21.5x6.6x
Sat, 22 Mar 2025US$829.3bUS$118.6b-US$36,904,224,937.6920.4x-22.5x7x
Mon, 17 Feb 2025US$842.1bUS$116.6b-US$36,838,613,842.2117.6x-22.9x7.2x
Wed, 15 Jan 2025US$933.0bUS$149.4b-US$26,267,408,194.2516.7x-35.5x6.2x
Fri, 13 Dec 2024US$1.0tUS$150.0b-US$26,532,638,861.6317.1x-38.5x6.8x
Sun, 10 Nov 2024US$1.1tUS$149.6b-US$27,286,902,976.6116.5x-40.7x7.4x
Tue, 08 Oct 2024US$889.8bUS$113.1b-US$35,895,408,227.4020.8x-24.8x7.9x
Thu, 05 Sep 2024US$889.8bUS$113.1b-US$35,706,110,149.3423.3x-24.9x7.9x
Sat, 03 Aug 2024US$1.2tUS$165.9b-US$33,221,382,510.8425.9x-36.6x7.3x
Mon, 01 Jul 2024US$1.1tUS$164.4b-US$27,988,781,321.0728.5x-41x7x
Wed, 29 May 2024US$1.1tUS$164.6b-US$26,663,229,028.4727.2x-42.2x6.8x
Fri, 26 Apr 2024US$1.1tUS$164.2b-US$23,382,193,080.9720.1x-46x6.6x
Sun, 24 Mar 2024US$1.2tUS$164.3b-US$23,936,586,653.3521.4x-48.6x7.1x
Tue, 20 Feb 2024US$1.2tUS$169.1b-US$20,394,485,082.3215.7x-57.5x6.9x
Thu, 18 Jan 2024US$1.4tUS$204.8b-US$22,506,707,794.0018.8x-63.3x7x
Sat, 16 Dec 2023US$1.4tUS$204.7b-US$22,119,635,723.0019.2x-61x6.6x
Mon, 13 Nov 2023US$1.2tUS$204.5b-US$21,996,116,562.0018.5x-54.6x5.9x
Wed, 11 Oct 2023US$1.3tUS$207.4b-US$13,069,383,940.0017.3x-96.7x6.1x
Fri, 08 Sep 2023US$1.3tUS$207.5b-US$12,639,999,993.0017.3x-100.8x6.1x
Sun, 06 Aug 2023US$1.3tUS$210.2b-US$10,135,599,050.0015.6x-124.3x6x
Tue, 04 Jul 2023US$1.1tUS$186.3b-US$16,037,705,056.0013.4x-69.9x6x
Thu, 01 Jun 2023US$1.1tUS$185.9b-US$16,012,100,305.0011.4x-69.8x6x
Sat, 29 Apr 2023US$1.2tUS$197.1b-US$6,647,559,484.0013.7x-174.1x5.9x
Price to Earnings Ratio

-174.1x


Total Market Cap: US$1.2tTotal Earnings: -US$6,647,559,484.00Total Revenue: US$197.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Biotech Industry Price to Earnings3Y Average -59.1x202420252026
Current Industry PE
  • Investors are optimistic on the American Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 6.8x is lower than the industry's current PS ratio of 8.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Revenues have also declined 5.7% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market3.58%
Healthcare0.51%
Biotech1.73%
Biotech1.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SMMT Summit TherapeuticsUS$26.3826.5%
+US$4.3b
-3.5%PB31x
BNTX BioNTechUS$111.6013.4%
+US$3.3b
6.6%PS8.4x
RVMD Revolution MedicinesUS$148.901.3%
+US$2.2b
304.0%PB19.2x
ERAS ErascaUS$22.4125.5%
+US$1.4b
1,523.9%PB21.4x
LEGN Legend BiotechUS$25.2234.9%
+US$1.2b
-26.9%PS4.5x

Latest News